Maximize Your Impact At DxPx US 2025
DxPx US 2025, taking place on July 29, 2025 at McCormick Place Convention Center in Chicago, is a pivotal event for executives across diagnostics, digital health, precision medicine, and life science tools. Known for its unique mix of industry-specific dealmaking and investment-focused networking, the event draws senior leadership from established companies and startups, along with private equity and venture capital stakeholders.
The business dynamic at DxPx US centers around growth partnerships, capital access, and commercial expansion. Many attendees are actively evaluating go-to-market partners, novel tools, and clinical solution opportunities. This makes it a high-impact setting for forming new alliances, introducing differentiated solutions, and connecting with hard-to-access innovators. The enriched attendee list from Vendelux offers insight into who is coming, their investment focus, company lifecycle stage, and current priorities—enabling teams to engage before the halls open.
How Sales, Marketing And Revops Teams Can Use This Attendee List
DxPx US 2025 attendees span decision-makers from biotech leaders, diagnostics firms, digital health startups, and global investment groups. These are highly targeted buyers evaluating tools and platforms across clinical validation, data science, and commercial infrastructure.
By using the enriched conference attendee list, teams can segment prospects based on company size, technology focus, and role—such as innovation leads, partnership directors, or investors. This kind of attendee data is essential for crafting outreach around strategic priorities like patient engagement, reimbursement readiness, or scale-up questions. Early engagement helps ensure you’re booking meetings with executives who hold budget authority and are ready to explore new collaborators.
On the floor, the same data can sharpen your in-event interactions, providing real-time context on who you’re meeting and why it matters. After the event, use that connection to continue conversations with relevant follow-up tied to investment timelines, clinical goals, or partnership themes. This is how to get more meetings and turn single interactions into strategic relationships.
Timing Is Everything
DxPx US 2025 takes place on July 29, 2025. With only one day to connect in person, early outreach is key. Using Vendelux, teams can access the attendee list in advance to align internal resources, personalize communications, and lock in time with top targets.
Given the event’s heavy emphasis on deal flow and business development, many executives arrive with calendars packed well before they land in Chicago. Starting your outreach in May and early June allows you to secure quality conversations and position your offerings before final prep and selection periods begin.
What’s Included In The DxPx US 2025 Attendee List?
Vendelux provides visibility into the executives expected to attend DxPx US 2025 through a combination of organizer-sourced data and proprietary signal analysis. Clients can upload a list of key accounts or targets to surface contacts already attending the show.
The enriched list includes first and last names, job titles, company names, company websites, location (city, state, country), LinkedIn profiles, verified email addresses, and phone numbers when available.
Where Is DxPx US 2025?
McCormick Place Convention Center | Chicago, Illinois, United States
When Is DxPx US 2025?
July 29, 2025
What Type Of Event Is DxPx US 2025?
DxPx US 2025 is a diagnostics and digital health-focused partnering conference that brings together industry leaders, investors, and early-stage companies to form meaningful connections around commercialization, investment, and innovation. The event includes networking sessions, curated one-on-one meetings, keynotes, and fireside chats focused on trends and dealmaking strategies in the life sciences ecosystem.
How Many People Attend DxPx US 2025?
The event typically attracts over 600 attendees from across the United States and Europe, with a strong concentration of C-level executives, business development leads, R&D heads, and investors. Participants come from diagnostics, biotech, medtech, digital health, and capital investment sectors.
